Eli Lilly Savings Card for Zepbound: How to Save Up to $650 Per Fill

If your doctor has prescribed Zepbound for weight management, you've probably experienced sticker shock at the pharmacy. With a list price exceeding $1,000 per month, this breakthrough medication can feel financially out of reach—even with insurance. The good news? Eli Lilly offers a savings card that could reduce your out-of-pocket costs to as little as $25 per fill, potentially saving you hundreds of dollars monthly.

Understanding how this savings program works, who qualifies, and what alternatives exist when you don't can make the difference between affording your treatment and having to stop altogether.

What Is the Eli Lilly Savings Card for Zepbound?

The Zepbound Savings Card is a manufacturer coupon program designed by Eli Lilly to help patients with commercial insurance afford their medication. It's not insurance itself, but rather a discount that applies at the pharmacy counter to reduce what you pay out-of-pocket.

When you use the savings card, Eli Lilly covers a portion of your prescription cost after your insurance processes the claim. This can make a dramatic difference in affordability, especially during those expensive early months when you're working through your insurance deductible.

Maximum Savings Available

The Zepbound savings card offers up to $650 in savings per 28-day prescription. For many patients, this brings the monthly cost down to just $25. However, your actual savings depend on your insurance coverage and what your plan negotiates as the prescription price.

The program has an annual maximum benefit of $7,800, which typically covers a full year of treatment if you're receiving monthly prescriptions.

Who Qualifies for the Zepbound Savings Card?

Not everyone can use the Eli Lilly savings card. Eligibility requirements are specific and strictly enforced at the pharmacy level.

You May Qualify If:

• You have commercial or private health insurance that covers Zepbound
• You're 18 years or older
• You have a valid prescription for Zepbound
• You're a resident of the United States or Puerto Rico

You Do NOT Qualify If:

• You're enrolled in Medicare, Medicaid, or any other federal or state-funded insurance program
• You're using TRICARE or any military health benefit
• You have no insurance at all (are paying cash)
• Your insurance doesn't cover Zepbound at all

This last point is critical and causes confusion. The savings card only works with commercial insurance coverage, not instead of it. If your plan excludes weight-loss medications entirely, the card won't help.

How to Get and Use Your Zepbound Savings Card

Activating your savings is straightforward, though you'll want to do this before heading to the pharmacy.

Step 1: Download or Request Your Card

Visit the official Zepbound savings card website (through Lilly's patient resources) to download a digital card or request a physical card be mailed to you. The digital version works immediately and can be shown on your smartphone at the pharmacy.

Step 2: Share Card Information With Your Pharmacy

When dropping off your prescription, tell the pharmacist you have a manufacturer savings card. Provide the card number, group number, and BIN/PCN codes. Most major pharmacy chains are familiar with these programs and know how to process them.

Step 3: Let Insurance Process First

Your insurance must adjudicate the claim first. Then the savings card applies to whatever out-of-pocket amount remains. You'll pay the reduced copay at pickup, typically $25 if you're within the savings maximum.

Step 4: Renew as Needed

Some versions of the card require annual re-enrollment. Check the expiration date on your card and set a reminder to reactivate before it expires to avoid unexpected costs.

What If You Don't Qualify?

If you're on Medicare, uninsured, or your plan doesn't cover Zepbound, you're not out of options—though finding affordable access requires looking beyond the brand name medication.

Compounded Tirzepatide

Compounded versions of tirzepatide (the active ingredient in Zepbound) have become available through specialized pharmacies. These are custom-made medications that contain the same active ingredient but aren't the brand-name product. They're often significantly less expensive and don't require insurance.

Patient Assistance Programs

Eli Lilly offers a separate patient assistance program for those who are uninsured or underinsured and meet income requirements. This is different from the savings card and requires an application with financial documentation.

Alternative GLP-1 Medications

If Zepbound specifically isn't affordable, talk with your doctor about whether other GLP-1 medications like semaglutide might be covered differently by your insurance plan. Coverage varies widely between medications and insurance carriers.

A Note on Gender and Weight Loss Medication Costs

While both men and women face the same list prices for Zepbound, research shows women are more likely to carry the mental load of managing household healthcare costs and medication logistics. Women also statistically face more insurance denials for weight-loss medications despite similar or greater medical need.

If you're navigating insurance appeals or prior authorization requirements, know that persistence often pays off. Many initial denials are overturned on appeal, especially when your physician provides thorough documentation of medical necessity.

From the Ozari Care Team

Before starting any GLP-1 medication, ensure you understand the full cost picture for at least six months of treatment. Weight management with medications like Zepbound works best with consistent use over time. Starting and stopping due to cost fluctuations can affect your results and make it harder to reach your health goals.

Affordable GLP-1 Options at Ozari Health

At Ozari Health, we offer compounded Semaglutide and Tirzepatide starting at $99/month, prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 29, 2026